Lumos Diagnostics
Lumos Diagnostics (ASX: LDX) Falls Despite FDA Win- Here’s Why the Dip Could Be a Buying Opportunity
Lumos Diagnostics Falls After FDA Waiver Lumos Diagnostics (ASX: LDX) slipped around 3.8% on Friday despite announcing one of the most important milestones in its history. The US Food and Drug Administration granted a CLIA waiver for its flagship FebriDx test, a development that expands the company's addressable US market by 15 times. The dip…
silex
Silex Systems (ASX: SLX) Surges 13.5% as Iran Tensions Revive Nuclear Energy: Buy Now or Wait for a Pullback?
Silex gains on nuclear demand, but risks remain Silex Systems (ASX: SLX) surged 13.5% to A$5.55 earlier this week as escalating tensions in the Middle East pushed investors towards nuclear energy and fuel security stocks. The Iran conflict reminded markets just how vulnerable the West remains when it comes to uranium enrichment supply, and Silex…
Ex-Dividend
ASX Rallies on Iran War Hopes: Buy Gold Miners or Avoid Energy Stocks Before Saturday?
ASX Surges on Iran Hopes: What Investors Do Now Wednesday's 1.85% rally already feels like a distant memory as the market grapples with a harsh reality check. The ASX surged after US President Donald Trump announced a five-day pause on military strikes against Iranian energy infrastructure, raising hopes the four-week-old Middle East war could be…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here